GPhA touts benefits of counter-detailing programs Eli Lilly, Transition Therapeutics ink deal for diabetes treatments FDA panel recommends restricting anemia drug to chemo patients FDA approves Abbott Freestyle Navigator glucose monitoring system GPhA calls Congressional biosimilar bill ‘disappointing’ NACDS, NCPA voice approval of CMS’ redefinition of multiple source drugs Avalere study shows Part D alleviates financial burden on those with diabetes Warning of liver damage issued for Prezista AstraZeneca announces plans to provide more company information on its Web site Duane Reade reports increased sales, narrows quarterly loss First Previous 2546 2547 2548 2549 2550 Next Last
